ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $160,584 | +10.3% | 74,690 | 0.0% | 0.00% | – |
Q1 2023 | $145,646 | -49.2% | 74,690 | 0.0% | 0.00% | – |
Q4 2022 | $286,810 | -21.4% | 74,690 | 0.0% | 0.00% | – |
Q3 2022 | $365,000 | -50.3% | 74,690 | -19.1% | 0.00% | -100.0% |
Q2 2022 | $734,000 | -45.9% | 92,290 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $1,356,000 | -27.3% | 92,290 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $1,864,000 | -25.6% | 92,290 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $2,507,000 | +41.4% | 92,290 | +9.5% | 0.00% | +50.0% |
Q2 2021 | $1,773,000 | -13.8% | 84,290 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $2,058,000 | +22.5% | 84,290 | +60.6% | 0.00% | 0.0% |
Q4 2020 | $1,680,000 | – | 52,489 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 1,186,215 | $9,430,000 | 5.29% |
GCM Grosvenor Holdings, LLC | 1,298,012 | $10,319,000 | 2.33% |
Redmile Group, LLC | 7,512,029 | $59,721,000 | 2.28% |
MPM BioImpact LLC | 334,384 | $2,658,000 | 0.74% |
Indie Asset Partners, LLC | 93,989 | $747,000 | 0.66% |
Eventide Asset Management | 1,879,959 | $14,946,000 | 0.32% |
Walleye Capital LLC | 888,700 | $7,065,000 | 0.20% |
Endurant Capital Management LP | 58,967 | $469,000 | 0.16% |
HHLR ADVISORS, LTD. | 500,000 | $3,975,000 | 0.08% |
Matrix Capital Management Company, LP | 400,000 | $3,180,000 | 0.07% |